AstraZeneca Expands Prescription Savings Program

WILMINGTON, Del., July 23 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN)
announced today it is expanding its prescription savings program by
immediately extending assistance to qualifying patients who have recently lost
their jobs, had their incomes reduced, or experienced a change in marital
status or family size.

Previously, patients who experienced a change in income or family size had
difficulty applying to the program if their W2 statements showed a
non-qualifying income. Now, qualifying people who provide documentation of
their current income and family size can enroll more easily and receive their
AstraZeneca medicines more quickly.

"AstraZeneca is committed to helping patients get the medicines they need,"
said Rich Fante, US President, AstraZeneca Pharmaceuticals LP. "Our
responsibility goes beyond developing medicines to also making them available
to those who cannot afford them."

For more than 30 years, AstraZeneca has offered patient assistance programs
side-by-side with its medicines. In 2008, AstraZeneca helped more than 440,000
people fill 2.7 million prescriptions resulting in $612 million of savings to
patients.

AstraZeneca provides free or low-cost medicines to patients through its
AZ&Me(TM) Prescription Savings programs in three ways:
-- AZ&Me(TM) Prescription Savings program for people without insurance:
AstraZeneca provides AstraZeneca medicines at no cost to qualifying
individuals without prescription drug coverage who make up to $30,000
per year and families of four who make up to $60,000 per year.
-- AZ&Me(TM) Prescription Savings program for people with Medicare Part
D: AstraZeneca provides low-cost AstraZeneca medicines for qualifying
Medicare Part D patients who make up to $30,000 per year or couples
who
make up to $40,000 per year.

-- AZ&Me(TM) Prescription Savings program for healthcare facilities:
AstraZeneca provides AstraZeneca medicines at no cost to qualifying
non-profit healthcare facilities, such as disproportionate share
hospitals, community health centers and community free clinics. This
program connects patients to the AstraZeneca medicines they need at
the
same time and place they receive their treatment.

Patients can learn more about the AZ&Me(TM) Prescription Savings program at
www.azandme.com or by calling 1-800-AZandMe.

About AstraZeneca
AstraZeneca is engaged in the research, development, manufacturing and
marketing of meaningful prescription medicines and in the supply of healthcare
services. AstraZeneca is one of the world's leading pharmaceutical companies
with global healthcare sales of $31.6 billion and is a leader in
gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and
infectious disease medicines. In the United States, AstraZeneca is a $13.5
billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription
Savings programs, please visit: www.astrazeneca-us.com.

SOURCE AstraZeneca

Tony Jewell of AstraZeneca, +1-302-885-4594